- Exchange: BSE India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Syncom Formulations India Ltd
+ Add to WatchlistSYNF:IN
110.70 INR 3.35 2.94%As of 06:20:25 ET on 05/24/2013.
Snapshot for Syncom Formulations India Ltd (SYNF)
| Open: | 109.05 | Day's Range: | 108.50 - 112.00 | Volume: | 8,837 |
|---|---|---|---|---|---|
| Previous Close: | 114.05 | 52wk Range: | 33.50 - 129.00 | 1-Yr Rtn: | +217.68% |
Key Statistics for SYNF
| Current P/E Ratio (ttm) | 70.4324 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 4.2541 |
| Earnings Per Share (ttm) | 1.5717 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 2,469.09 |
| Shares Outstanding (M) | 22.30 |
| 30 Day Average Volume | 32,578 |
| Price/Book (mrq) | 2.9532 |
| Price/Sale (ttm) | 2.0845 |
| Dividend Indicated Gross Yield | 0.54% |
| Cash Dividend (INR) | 0.6000 |
| Last Dividend | 09/20/2012 |
| 5 Year Dividend Growth | -9.71% |
| Next Earnings Announcement | 05/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SYNF
No data available
Company Profile & Key Executives for SYNF
Syncom Formulations India Limited manufactures pharmaceuticals. The Company produces and promotes generic, herbal, and over-the-counter products.
| Kedarmal BankdaChairman/Exec Dir/Founder | Vijay Kumar BankdaManaging Director |
| Devendra Kumar MaheshwariGeneral Manager:Accounts | Shikha SethiSecretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SYNF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page